-
Mashup Score: 0
A recent prospective study examined the use of focal salvage reirradiation using external beam radiotherapy to determine its efficacy and feasibility.
Source: guoncologynow.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9
Drs. Ambinder and Sonpavde provide an update for CheckMate 901, characterizing treatment benefit in responders.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3Carboplatin, PD-1 Inhibitors Preferred Over Cisplatin-Based Regimens for aUC in New Study | GU Oncology Now - 1 day(s) ago
A new study recorded data on the type of treatment received in each line of therapy for advanced urothelial carcinoma, as well as the attrition rates.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3The Uromigos Episode 313: APCCC 2024 Debate - Radiation Therapy in Advanced Disease | GU Oncology Now - 2 day(s) ago
Drs. Thomas Zilli and Pierre Blanchard join The Uromigos at APCCC 2024 to debate the use of radiation therapy in prostate cancer and oligometastatic disease.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 8
Drs. Murray and Broenimann highlight and evaluation of urinary genomic profiling for detection and molecular staging of UTUC.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2TROP-2: Prognostic Significance for Penile Squamous Cell Carcinoma? | GU Oncology Now - 2 day(s) ago
A study to determine the potential utility of ADCs targeting TROP-2 in both localized PSCC and distant metastases.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5Genomic Signatures Associated With Adverse Pathologic Features at RP | GU Oncology Now - 3 day(s) ago
Dr. Li highlights the significance of adverse pathologic features at radical prostatectomy for AS-eligible patients.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1
Enzalutamide and lutetium-177βlabeled prostate-specific membrane antigen-617 have both been proven to improve OS rates in patients with mCRPC.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 14RCC Patient Selection, Counseling, and Improved Biomarkers, Imaging | GU Oncology Now - 4 day(s) ago
Drs. Joyce and Psutka consider patient counseling for adjuvant RCC therapy, and biomarkers and imaging before treatment.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4The Uromigos Episode 312: APCCC 2024 - Radiation Therapy After Surgery for Prostate Cancer | GU Oncology Now - 4 day(s) ago
Brian and Tom speak with Drs. Piet Ost and Jason Efstathiou at ASCCC 2024 to discuss the data for and against the use of radiation therapy in prostate cancer care.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
π A recent study sought to determine if re-treating patients with locally #recurrent #ProstateCancer with #EBRT is feasible. π Read More: https://t.co/PpjUWCk5lT https://t.co/3yd6ZxPjKb